SCHEMBL2149631

SCHEMBL2149631

Brc1ccccc1-c1cc2cc3oc(-c4ccccc4Br)cc3cc2o1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 7/20 0.76
▸ MAOA P21397 4/20 0.76
▸ TP53 P04637 3/20 0.41
▸ MAPT P10636 3/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.38
▸ C1R P00736 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ GABRP O00591 1/20 0.36
▸ GABRD O14764 1/20 0.36
▸ GABRA1 P14867 1/20 0.36
▸ GABRB1 P18505 1/20 0.36
▸ GABRG2 P18507 1/20 0.36
▸ GABRB3 P28472 1/20 0.36
▸ GABRA5 P31644 1/20 0.36
▸ GABRA3 P34903 1/20 0.36
▸ GABRA2 P47869 1/20 0.36
▸ GABRB2 P47870 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20174691 0.86 MAOB (1.00) MAOBMAOAMAPTKMT2ARAB9A
SCHEMBL12334463 0.81 MAOB (0.56) MAOBMAOAHDAC6KMT2ARAB9A
SCHEMBL11645570 0.75 MAOA (0.63) MAOBMAOATP53MAPTALDH1A1
SCHEMBL28961154 0.73 MAOB (0.75) MAOBMAOASMN1; SMN2ALDH1A1MAPK1
SCHEMBL27642428 0.73 MAOB (0.60) MAOBMAOAMAPTSMN1; SMN2ALDH1A1
SCHEMBL8025501 0.73 HPGD (0.67) MAOBMAOATP53MAPTSMN1; SMN2
SCHEMBL2149647 0.72 MAOB (0.76) MAOBMAOAMAPTALDH1A1KMT2A
SCHEMBL14528474 0.72 MAPK1 (0.55) MAOBMAOATP53MAPTSMN1; SMN2
SCHEMBL14231891 0.72 MAOB (0.44) MAOBMAOAMAPTALDH1A1RAB9A
SCHEMBL11672377 0.71 MAOB (0.72) MAOBMAOAMAPTKMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110166362-A1 NOVEL COMPOUND AND ORGANIC SEMICONDUCTOR MATERIAL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-07-07 — — US disclosed
EP-2341051-A1 NOVEL COMPOUND AND ORGANIC SEMICONDUCTOR MATERIAL Sumitomo Chemical Company, Limited (JP) 2011-07-06 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166362-A1 NOVEL COMPOUND AND ORGANIC SEMICONDUCTOR MATERIAL SCLY, MSRB3, SOD1 MAOB 180/4885MAOA 688/4885TP53 3788/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback